Mucinous adenocarcinomas, defined as tumors in which >50% of the lesion is composed of extracellular mucus, constitute a distinct histologic subtype and are associated with BRAF mutations, MSI status, and the CpG island methylator phenotype (CIMP) [52]. The gene discussed is BRAF; the disease is mucinous adenocarcinoma.